Dolby Laboratories Inc
For the period ended Mar 29, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2024 · Filed May 2, 2024
DLB$64.67-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Interim Condensed Consolidated Statements of Operations
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
| Fiscal Quarter Ended | Fiscal Year-To-Date Ended | |||
|---|---|---|---|---|
| March 29,2024 | March 31,2023 | March 29,2024 | March 31,2023 | |
| Revenue: | ||||
| Licensing | $338,240 | $351,608 | $632,007 | $659,619 |
| Products and services | 26,283 | 24,283 | 48,090 | 51,193 |
| Total revenue | 364,523 | 375,891 | 680,097 | 710,812 |
| Cost of revenue: | ||||
| Cost of licensing | 15,318 | 21,365 | 31,054 | 34,724 |
| Cost of products and services | 23,459 | 19,684 | 39,783 | 40,775 |
| Total cost of revenue | 38,777 | 41,049 | 70,837 | 75,499 |
| Gross profit | 325,746 | 334,842 | 609,260 | 635,313 |
| Operating expenses: | ||||
| Research and development | 62,493 | 67,951 | 129,526 | 132,401 |
| Sales and marketing | 90,038 | 95,695 | 169,041 | 177,900 |
| General and administrative | 66,742 | 61,939 | 131,908 | 121,911 |
| Restructuring charges/(credits) | (2,495) | 33 | 3,596 | (211) |
| Total operating expenses | 216,778 | 225,618 | 434,071 | 432,001 |
| Operating income | 108,968 | 109,224 | 175,189 | 203,312 |
| Other income/(expense): | ||||
| Interest income/(expense), net | 8,597 | 6,807 | 17,784 | 11,604 |
| Other income, net | 4,183 | 1,250 | 9,608 | 2,347 |
| Total other income | 12,780 | 8,057 | 27,392 | 13,951 |
| Income before income taxes | 121,748 | 117,281 | 202,581 | 217,263 |
| Provision for income taxes | (23,534) | (21,398) | (36,786) | (41,932) |
| Net income including noncontrolling interest | 98,214 | 95,883 | 165,795 | 175,331 |
| Less: net income attributable to noncontrolling interest | (384) | (187) | (984) | (260) |
| Net income attributable to Dolby Laboratories, Inc. | $97,830 | $95,696 | $164,811 | $175,071 |
| Net income per share: | ||||
| Basic | $1.02 | $1.00 | $1.72 | $1.83 |
| Diluted | $1.01 | $0.98 | $1.69 | $1.80 |
| Weighted-average shares outstanding: | ||||
| Basic | 95,718 | 95,820 | 95,547 | 95,862 |
| Diluted | 96,856 | 97,298 | 97,397 | 97,392 |
| Related party rent expense: | ||||
| Included in net income attributable to noncontrolling interest | $71 | $71 | $142 | $142 |
| Cash dividend declared per common share | $0.30 | $0.27 | $0.60 | $0.54 |
| Cash dividend paid per common share | $0.30 | $0.27 | $0.60 | $0.54 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.